Imugene(IUGNF)
$0.030.00 (0.00%)
IUGNF
Imugene financials statements
$0.03
At close:0.00 (0.00%)
Imugene (IUGNF) Ratios
40 Followers
Imugene Ratios
IUGNF's free cash flow for Q4 2026 was AU$-18.88M. For the 2026 fiscal year, IUGNF's free cash flow was increased by AU$0.00 and operating cash flow was AU$-18.88M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.70 | 1.88 | 3.86 | 27.23 | 15.32 |
| Quick Ratio | 0.39 | 1.88 | 3.86 | 27.23 | 15.32 |
| Cash Ratio | 0.19 | 0.99 | 3.18 | 25.17 | 13.45 |
| Solvency Ratio | -7.02 | -1.70 | -4.34 | -4.80 | -3.98 |
| Operating Cash Flow Ratio | -3.20 | -3.41 | -3.47 | -4.89 | -4.13 |
| Short-Term Operating Cash Flow Coverage | -7.12 | -11.34 | -111.49 | -155.86 | -166.54 |
| Net Current Asset Value | AU$ -4.20M | AU$ 3.19M | AU$ 79.89M | AU$ 158.22M | AU$ 104.87M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.13 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.70 | 0.24 | 0.02 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.41 | 0.19 | 0.02 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.56 | 1.86 | 1.28 | 1.04 | 1.06 |
| Debt Service Coverage Ratio | -10.29 | -9.17 | -103.08 | -163.30 | -179.27 |
| Interest Coverage Ratio | -597.34 | -436.59 | -294.61 | -1868.39 | -3731.45 |
| Debt to Market Cap | 0.17 | 0.10 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.05 | 0.01 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.05 | 0.17 | 0.61 | 3.22 | 2.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 100.00% | 81.29% | 81.44% |
| EBIT Margin | 0.00% | -1593.52% | -3094.91% | -421.37% | -389.13% |
| EBITDA Margin | 0.00% | -1516.55% | -2977.41% | -402.66% | -370.56% |
| Operating Profit Margin | 0.00% | -1613.45% | -2835.62% | -435.50% | -390.70% |
| Pretax Profit Margin | 0.00% | -1569.81% | -3104.53% | -421.60% | -389.23% |
| Net Profit Margin | 0.00% | -1569.81% | -3011.67% | -321.91% | -291.97% |
| Continuous Operations Profit Margin | 0.00% | -1477.84% | -3011.67% | -321.91% | -291.97% |
| Net Income Per EBT | 98.14% | 100.00% | 97.01% | 76.36% | 75.01% |
| EBT Per EBIT | 143.21% | 97.30% | 109.48% | 96.81% | 99.62% |
| Return on Assets (ROA) | -457.36% | -82.57% | -98.87% | -19.24% | -25.66% |
| Return on Equity (ROE) | -1169.16% | -153.27% | -126.58% | -19.99% | -27.30% |
| Return on Capital Employed (ROCE) | -831.92% | -115.47% | -115.42% | -26.86% | -36.15% |
| Return on Invested Capital (ROIC) | -480.51% | -96.44% | -110.56% | -20.47% | -27.05% |
| Return on Tangible Assets | -579.64% | -133.01% | -127.63% | -22.76% | -32.95% |
| Earnings Yield | -280.89% | -71.40% | -38.39% | -6.65% | -3.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.44 | 0.39 | 0.97 | 1.02 |
| Payables Turnover | 1.23 | 0.49 | 0.98 | 0.94 | 0.53 |
| Inventory Turnover | 1.55 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 2.54 | 2.93 | 17.25 | 15.03 |
| Asset Turnover | 0.00 | 0.05 | 0.03 | 0.06 | 0.09 |
| Working Capital Turnover Ratio | 0.00 | 0.09 | 0.04 | 0.09 | 0.19 |
| Cash Conversion Cycle | -62.14 | 93.95 | 553.69 | -12.55 | -325.10 |
| Days of Sales Outstanding | 0.00 | 831.61 | 926.71 | 375.14 | 359.32 |
| Days of Inventory Outstanding | 235.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 297.31 | 737.66 | 373.02 | 387.69 | 684.42 |
| Operating Cycle | 235.18 | 831.61 | 926.71 | 375.14 | 359.32 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.14 | -0.35 | -0.49 | -0.16 | -0.18 |
| Free Cash Flow Per Share | -0.14 | -0.41 | -0.52 | -0.16 | -0.19 |
| Dividend Paid and CapEx Coverage Ratio | -8970953.00 | -5.23 | -14.38 | 0.00 | -119.02 |
| Capital Expenditure Coverage Ratio | -8970953.00 | -5.23 | -14.38 | 0.00 | -119.02 |
| Operating Cash Flow Coverage Ratio | -7.12 | -7.09 | -46.38 | -53.80 | -45.54 |
| Operating Cash Flow to Sales Ratio | 0.00 | -17.19 | -20.47 | -2.53 | -2.36 |
| Free Cash Flow Yield | -119.61% | -93.13% | -27.91% | -5.22% | -3.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.36 | -1.38 | -2.60 | -15.04 | -26.79 |
| Price-to-Sales (P/S) Ratio | 0.00 | 21.99 | 78.45 | 48.42 | 78.23 |
| Price-to-Book (P/B) Ratio | 4.16 | 2.15 | 3.30 | 3.01 | 7.32 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.84 | -1.07 | -3.58 | -19.15 | -32.81 |
| Price-to-Operating Cash Flow Ratio | -0.84 | -1.28 | -3.83 | -19.15 | -33.09 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.02 | -0.01 | 1.73 | -0.35 |
| Enterprise Value Multiple | -0.60 | -1.28 | -2.02 | -8.81 | -19.05 |
| Enterprise Value | 41.17M | 85.38M | 298.97M | 417.75M | 915.48M |
| EV to EBITDA | -0.60 | -1.28 | -2.02 | -8.81 | -19.05 |
| EV to Sales | 0.00 | 19.42 | 60.15 | 35.47 | 70.58 |
| EV to Free Cash Flow | -0.92 | -0.95 | -2.75 | -14.03 | -29.60 |
| EV to Operating Cash Flow | -0.92 | -1.13 | -2.94 | -14.03 | -29.85 |
| Tangible Book Value Per Share | 0.01 | 0.06 | 0.40 | 0.86 | 0.64 |
| Shareholders’ Equity Per Share | 0.03 | 0.21 | 0.57 | 1.03 | 0.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.06 | 0.03 | 0.24 | 0.25 |
| Revenue Per Share | 0.00 | 0.02 | 0.02 | 0.06 | 0.08 |
| Net Income Per Share | -0.32 | -0.32 | -0.72 | -0.21 | -0.23 |
| Tax Burden | 0.98 | 1.00 | 0.97 | 0.76 | 0.75 |
| Interest Burden | 1.43 | 0.99 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 10.62 | 17.48 | 2.62 | 2.82 |
| SG&A to Revenue | 0.00 | 6.32 | 12.05 | 1.51 | 0.93 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.48 | 0.32 |
| Income Quality | 0.43 | 1.09 | 0.68 | 0.79 | 0.81 |
Currency in AUD

